Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Linde
LIN
|
+$998M |
| 2 |
Microsoft
MSFT
|
+$721M |
| 3 |
Apple
AAPL
|
+$557M |
| 4 |
Amazon
AMZN
|
+$457M |
| 5 |
Cigna
CI
|
+$356M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
+$741M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$651M |
| 3 |
PX
Praxair Inc
PX
|
+$555M |
| 4 |
COL
Rockwell Collins
COL
|
+$293M |
| 5 |
CA
CA, Inc.
CA
|
+$178M |
Sector Composition
| 1 | Technology | 17.66% |
| 2 | Financials | 15.19% |
| 3 | Healthcare | 14.85% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CONN
2126
DELISTED
Conn's Inc.
CONN
| $5.61M | ﹤0.01% |
297,414
-40,015
| -12% | -$755K |
|
|
RARX
2127
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $5.6M | ﹤0.01% |
307,514
+123,539
| +67% | +$2.25M |
|
2128
Akebia Therapeutics
AKBA
$793M
| $5.59M | ﹤0.01% |
1,011,544
+373,594
| +59% | +$2.07M |
|
|
CHCT
2129
Community Healthcare Trust
CHCT
$446M
| $5.59M | ﹤0.01% |
193,745
+10,370
| +6% | +$299K |
|
2130
Manitowoc
MTW
$363M
| $5.57M | ﹤0.01% |
376,811
+21,106
| +6% | +$312K |
|
|
EXPR
2131
DELISTED
Express, Inc.
EXPR
| $5.57M | ﹤0.01% |
54,464
+1,688
| +3% | +$172K |
|
2132
Apellis Pharmaceuticals
APLS
$3.21B
| $5.56M | ﹤0.01% |
421,849
+48,603
| +13% | +$641K |
|
2133
RPC Inc
RES
$1.03B
| $5.56M | ﹤0.01% |
563,541
+21,068
| +4% | +$208K |
|
|
PDLI
2134
DELISTED
PDL BioPharma, Inc.
PDLI
| $5.54M | ﹤0.01% |
1,910,568
+45,573
| +2% | +$132K |
|
|
WSR
2135
Whitestone REIT
WSR
$670M
| $5.52M | ﹤0.01% |
450,254
+43,197
| +11% | +$530K |
|
2136
Champion Homes, Inc.
SKY
$4.31B
| $5.52M | ﹤0.01% |
375,681
+235,422
| +168% | +$3.46M |
|
|
IPHS
2137
DELISTED
Innophos Holdings, Inc.
IPHS
| $5.49M | ﹤0.01% |
223,850
+12,229
| +6% | +$300K |
|
2138
John B. Sanfilippo & Son
JBSS
$745M
| $5.49M | ﹤0.01% |
98,627
+7,106
| +8% | +$395K |
|
2139
Donnelley Financial Solutions
DFIN
$1.54B
| $5.48M | ﹤0.01% |
390,542
+39,212
| +11% | +$550K |
|
2140
DMC Global
BOOM
$145M
| $5.47M | ﹤0.01% |
155,853
+10,755
| +7% | +$378K |
|
2141
Comscore
SCOR
$32.2M
| $5.47M | ﹤0.01% |
18,965
-1,058
| -5% | -$305K |
|
2142
Customers Bancorp
CUBI
$2.33B
| $5.47M | ﹤0.01% |
300,429
+15,289
| +5% | +$278K |
|
2143
Collegium Pharmaceutical
COLL
$1.23B
| $5.45M | ﹤0.01% |
317,449
+31,301
| +11% | +$537K |
|
2144
Ennis
EBF
$473M
| $5.44M | ﹤0.01% |
282,456
+4,954
| +2% | +$95.4K |
|
2145
CEVA Inc
CEVA
$570M
| $5.43M | ﹤0.01% |
245,934
+7,156
| +3% | +$158K |
|
|
TSG
2146
DELISTED
The Stars Group Inc.
TSG
| $5.42M | ﹤0.01% |
330,195
+136,082
| +70% | +$2.24M |
|
2147
First Foundation Inc
FFWM
$497M
| $5.42M | ﹤0.01% |
421,579
+64,722
| +18% | +$832K |
|
|
CTRL
2148
DELISTED
Control4 Corporation
CTRL
| $5.4M | ﹤0.01% |
306,660
-34,946
| -10% | -$615K |
|
2149
Liberty Energy
LBRT
$1.8B
| $5.4M | ﹤0.01% |
416,728
-41,952
| -9% | -$543K |
|
2150
Precigen
PGEN
$1.23B
| $5.38M | ﹤0.01% |
823,148
+56,831
| +7% | +$372K |
|